HUE045015T2 - Eljárás mycoplasma vakcina elõállítására - Google Patents

Eljárás mycoplasma vakcina elõállítására

Info

Publication number: HUE045015T2
Authority: HU; Hungary
Prior art keywords: making; mycoplasma vaccine; mycoplasma; vaccine
Prior art date: 2012-12-28

Application number

Other languages

English (en)

Inventor

Dianna M Murphy Jordan

Brian Thomas Martinson

Christine Margaret Muehlenthaler

Axel Neubauer

Arun V Iyer

Original Assignee

Boehringer Ingelheim Vetmedica Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-12-28

Filing date

2013-12-20

Publication date

2019-11-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49917778&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE045015(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-12-20 Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh

2019-11-28 Publication of HUE045015T2 publication Critical patent/HUE045015T2/hu

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/70—Non-animal cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Immunology (AREA)
Cell Biology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Developmental Biology & Embryology (AREA)
Medicinal Preparation (AREA)

HUE13817835 2012-12-28 2013-12-20 Eljárás mycoplasma vakcina elõállítására HUE045015T2 (hu)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201261746997P	2012-12-28	2012-12-28

Publications (1)

Publication Number	Publication Date
HUE045015T2 true HUE045015T2 (hu)	2019-11-28

Family

ID=49917778

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HUE13817835 HUE045015T2 (hu)	2012-12-28	2013-12-20	Eljárás mycoplasma vakcina elõállítására

Country Status (23)

Country	Link
US (2)	US9273281B2 (hu)
EP (1)	EP2938747B1 (hu)
JP (2)	JP6122146B2 (hu)
KR (1)	KR102153275B1 (hu)
CN (2)	CN108379571A (hu)
AR (1)	AR094648A1 (hu)
AU (1)	AU2013370983B2 (hu)
BR (1)	BR112015012711B1 (hu)
CA (1)	CA2896298C (hu)
CL (1)	CL2015001562A1 (hu)
DK (1)	DK2938747T3 (hu)
EA (1)	EA032772B1 (hu)
ES (1)	ES2738100T3 (hu)
HU (1)	HUE045015T2 (hu)
MX (1)	MX361273B (hu)
MY (1)	MY173223A (hu)
PH (1)	PH12015501333A1 (hu)
PL (1)	PL2938747T3 (hu)
PT (1)	PT2938747T (hu)
SG (2)	SG10201708028VA (hu)
TW (2)	TWI618542B (hu)
UA (1)	UA121193C2 (hu)
WO (1)	WO2014105672A1 (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8546149B2 (en)	2010-08-27	2013-10-01	Intervet Inc.	Potency test for vaccine formulations
CN108379571A (zh)	2012-12-28	2018-08-10	勃林格殷格翰动物保健有限公司	支原体疫苗的制备方法
CN110227151B (zh) *	2012-12-28	2024-06-14	勃林格殷格翰动物保健有限公司	包含支原体抗原的免疫原性组合物
CN105441368B (zh) *	2016-01-19	2019-01-01	福清市默克兽医院	一株牛支原体及其应用
WO2017132578A1 (en) *	2016-01-29	2017-08-03	Advanced Animal Diagnostics, Inc.	Methods and compositions for detecting mycoplasma exposure
EP3498728A4 (en) *	2016-08-09	2020-03-25	Agricultural Technology Research Institute	COMPOSITION FOR THE PREVENTION AND TREATMENT OF MYCOPLASMA HYORHINIS
EP3576799A4 (en) *	2017-02-03	2020-12-30	The Administrators of The Tulane Educational Fund	OPHTHALMIC COMPOSITIONS FOR THERAPY AND PROPHYLAXIS
CN110650989B (zh)	2017-05-24	2023-03-31	三菱化学株式会社	成型材料、及纤维增强复合材料
US20220235313A1 (en)	2019-06-10	2022-07-28	ELANCO US, Inc.	Mycoplasma media formulations
CN113201050B (zh) *	2020-08-06	2022-07-22	青岛诺安百特生物技术有限公司	一种金黄色葡萄球菌噬菌体穿孔素及其制备方法和应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2909462A (en)	1955-12-08	1959-10-20	Bristol Myers Co	Acrylic acid polymer laxative compositions
GB1074920A (en) *	1965-04-21	1967-07-05	Pfizer & Co C	Growth medium for mycoplasma pneumoniae and vaccine production
ES343655A1 (es)	1966-07-11	1968-09-01	Research Corp	Metodo para la preparacion de un inoculo para aves de co- rral.
JPS5540568B2 (hu)	1972-10-05	1980-10-18
US5338543A (en)	1992-02-27	1994-08-16	Ambico, Inc.	Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5885823A (en) *	1995-06-05	1999-03-23	Nobl Laboratories, Inc.	Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
DE60142506D1 (de) *	2000-03-03	2010-08-19	Chemo Sero Therapeut Res Inst	In serumfreier kultur verwendbare zelle, kultursuspension und verfahren zur virusproduktion als impfstoff unter verwendung der zelle
JP3402304B2 (ja) *	2000-03-30	2003-05-06	株式会社微生物化学研究所	猫クラミジアワクチンの製造方法
US7018638B2 (en)	2000-12-19	2006-03-28	Wyeth	Mycoplasma hyopneumoniae bacterin vaccine
MY129765A (en)	2000-12-19	2007-04-30	Wyeth Corp	Improved mycoplasma hyopneumoniae bacterin vaccine
WO2003004051A2 (en)	2001-07-02	2003-01-16	Pfizer Products Inc.	Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
US20030147914A1 (en)	2001-07-02	2003-08-07	Pfizer Inc.	Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
PL209773B1 (pl)	2001-07-02	2011-10-31	Pfizer Prod Inc	Zastosowanie bakteryny Mycoplasma hyopneumoniae do wytwarzania szczepionki
HUP0401077A3 (en)	2001-08-28	2004-10-28	Pfizer Prod Inc	Mycoplasma bovis challenge model, methods for administering m. bovis and methods for inducing pneumonic lung lesions
TWI238721B (en) *	2003-06-20	2005-09-01	Animal Technology Inst Taiwan	Swine enzootic vaccine, its producing method and usage
CA2595556A1 (en)	2005-02-09	2006-08-17	Magna International Inc.	Method of manufacturing a semi-structural panel
JP4693839B2 (ja) *	2005-03-10	2011-06-01	共立製薬株式会社	動物由来の成分なしで培養可能である細胞株及びその作出方法、これを用いたウイルスの生産方法、及びワクチンの生産方法
JP2009512426A (ja) *	2005-10-14	2009-03-26	イヴァン・ペテャエフ	偏性細胞内病原体の治療および診断
CN101627113B (zh)	2006-09-15	2013-04-24	米迪缪尼有限公司	支持病毒生长到高效价的mdck细胞系和采用该细胞系的生物反应器方法
US20090068231A1 (en)	2007-09-11	2009-03-12	Wyeth	Live attenuated mycoplasma strains
AR069087A1 (es)	2007-10-29	2009-12-30	Boehringer Ingelheim Vetmed	Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
JP5869221B2 (ja)	2007-11-06	2016-02-24	ゾエティス・ダブリュー・エルエルシー	アジュバント添加マイコプラズマ・ハイオニューモニエ非病原性生ワクチン
CA2712006A1 (en)	2008-01-23	2009-10-15	Boehringer Ingelheim Vetmedica, Inc.	Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
US8444989B1 (en)	2008-04-18	2013-05-21	Boehringer Ingelheim Vetmedica Gmbh	One dose vaccination against mycoplasma infections of pigs
WO2009142086A1 (ja)	2008-05-23	2009-11-26	学校法人久留米大学	マイコプラズマ感染症用ワクチン組成物
BRPI0913954B1 (pt)	2008-06-27	2022-04-05	Zoetis Services Llc	Composições de vacina e uso das mesmas
EP2362780B1 (en)	2008-10-31	2019-12-25	Boehringer Ingelheim Animal Health USA Inc.	Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
PE20120909A1 (es)	2009-05-19	2012-08-19	Bioproperties Pty Ltd	Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usos de la misma
WO2011075379A1 (en)	2009-12-18	2011-06-23	Boehringer Ingelheim Vetmedica, Inc.	Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine
US8112663B2 (en)	2010-03-26	2012-02-07	Lsi Corporation	Method to establish redundancy and fault tolerance better than RAID level 6 without using parity
CN102258776B (zh)	2011-07-07	2013-07-10	普莱柯生物工程股份有限公司	猪肺炎支原体、猪鼻支原体二联灭活疫苗及其制备方法
US9120859B2 (en)	2012-04-04	2015-09-01	Zoetis Services Llc	Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv та mycoplasma hyopneumoniae
CN108379571A (zh)	2012-12-28	2018-08-10	勃林格殷格翰动物保健有限公司	支原体疫苗的制备方法
CN110227151B (zh) *	2012-12-28	2024-06-14	勃林格殷格翰动物保健有限公司	包含支原体抗原的免疫原性组合物

2013
- 2013-12-20 CN CN201810161003.1A patent/CN108379571A/zh active Pending
- 2013-12-20 EA EA201500701A patent/EA032772B1/ru not_active IP Right Cessation
- 2013-12-20 DK DK13817835.5T patent/DK2938747T3/da active
- 2013-12-20 MY MYPI2015001621A patent/MY173223A/en unknown
- 2013-12-20 KR KR1020157020447A patent/KR102153275B1/ko active IP Right Grant
- 2013-12-20 AU AU2013370983A patent/AU2013370983B2/en not_active Ceased
- 2013-12-20 ES ES13817835T patent/ES2738100T3/es active Active
- 2013-12-20 CA CA2896298A patent/CA2896298C/en active Active
- 2013-12-20 WO PCT/US2013/076807 patent/WO2014105672A1/en active Application Filing
- 2013-12-20 PL PL13817835T patent/PL2938747T3/pl unknown
- 2013-12-20 BR BR112015012711-8A patent/BR112015012711B1/pt active IP Right Grant
- 2013-12-20 PT PT13817835T patent/PT2938747T/pt unknown
- 2013-12-20 EP EP13817835.5A patent/EP2938747B1/en active Active
- 2013-12-20 US US14/135,796 patent/US9273281B2/en active Active
- 2013-12-20 UA UAA201507463A patent/UA121193C2/uk unknown
- 2013-12-20 HU HUE13817835 patent/HUE045015T2/hu unknown
- 2013-12-20 JP JP2015549759A patent/JP6122146B2/ja active Active
- 2013-12-20 MX MX2015007730A patent/MX361273B/es active IP Right Grant
- 2013-12-20 CN CN201380066001.XA patent/CN104968365B/zh active Active
- 2013-12-20 SG SG10201708028VA patent/SG10201708028VA/en unknown
- 2013-12-20 SG SG11201505089YA patent/SG11201505089YA/en unknown
- 2013-12-27 TW TW102148875A patent/TWI618542B/zh active
- 2013-12-27 TW TW107103700A patent/TWI660736B/zh active
- 2013-12-27 AR ARP130105050A patent/AR094648A1/es unknown
2015
- 2015-06-05 CL CL2015001562A patent/CL2015001562A1/es unknown
- 2015-06-15 PH PH12015501333A patent/PH12015501333A1/en unknown
2016
- 2016-01-19 US US15/000,342 patent/US10512680B2/en active Active
2017
- 2017-03-30 JP JP2017067820A patent/JP6449364B2/ja active Active

Also Published As

Publication number	Publication date
EP2938747A1 (en)	2015-11-04
SG11201505089YA (en)	2015-07-30
TWI660736B (zh)	2019-06-01
DK2938747T3 (da)	2019-08-05
EA032772B1 (ru)	2019-07-31
BR112015012711A2 (pt)	2017-07-11
CN108379571A (zh)	2018-08-10
MY173223A (en)	2020-01-07
JP2016508983A (ja)	2016-03-24
PT2938747T (pt)	2019-08-01
KR20150100920A (ko)	2015-09-02
TW201438732A (zh)	2014-10-16
CN104968365A (zh)	2015-10-07
CL2015001562A1 (es)	2016-06-24
ES2738100T3 (es)	2020-01-20
TW201832777A (zh)	2018-09-16
SG10201708028VA (en)	2017-10-30
MX361273B (es)	2018-12-03
CA2896298C (en)	2024-01-16
US20140186394A1 (en)	2014-07-03
US9273281B2 (en)	2016-03-01
UA121193C2 (uk)	2020-04-27
CN104968365B (zh)	2018-04-03
KR102153275B1 (ko)	2020-09-09
JP6449364B2 (ja)	2019-01-09
JP6122146B2 (ja)	2017-04-26
AU2013370983A1 (en)	2015-05-21
BR112015012711B1 (pt)	2022-08-16
EP2938747B1 (en)	2019-05-01
EA201500701A1 (ru)	2015-12-30
US20160136254A1 (en)	2016-05-19
AU2013370983B2 (en)	2019-09-26
AR094648A1 (es)	2015-08-19
WO2014105672A1 (en)	2014-07-03
PL2938747T3 (pl)	2019-11-29
TWI618542B (zh)	2018-03-21
CA2896298A1 (en)	2014-07-03
JP2017145253A (ja)	2017-08-24
MX2015007730A (es)	2015-09-07
US10512680B2 (en)	2019-12-24
PH12015501333A1 (en)	2015-09-02

Publication	Publication Date	Title
HK1207967A1 (en)	2016-02-19	Vaccine
SG11201505089YA (en)	2015-07-30	Method of making a mycoplasma vaccine
GB2501243B (en)	2014-06-18	Method of making a medical balloon
EP2913831A4 (en)	2015-11-25	PROCESS FOR PRODUCING RARE EARTH MAGNET
EP2939754A4 (en)	2016-03-16	DRAWING FORM PROCEDURE
EP2876161A4 (en)	2016-03-23	VACCINE
GB201223386D0 (en)	2013-02-06	Vaccine
IL234024A0 (en)	2014-09-30	A method for making a multi-layered item
GB2517862B (en)	2017-03-01	Method of marking a line
PL2931937T3 (pl)	2017-05-31	Sposób wytwarzania układów nanocząstek metali
SG11201504454RA (en)	2015-07-30	A method of vitrification
PL2809816T3 (pl)	2019-04-30	Sposób ekspresji
EP2824130A4 (en)	2015-10-14	PROCESS FOR PRODUCING POLYDIALKYLSILANE
GB201220155D0 (en)	2012-12-26	Method of manufacture
LU92341B1 (en)	2015-04-29	Method of producing a shaped component
SG2013017017A (en)	2014-09-26	A method of separation
HRP20181348T1 (hr)	2018-11-16	Postupak izrade panela
SG2013085071A (en)	2014-07-30	Method of producing methionine
PL2662656T3 (pl)	2015-10-30	Sposób wykonania grzejnika
EP2832696A4 (en)	2015-11-04	MAYENITHERSTELLUNGSVERFAHREN
GB201215942D0 (en)	2012-10-24	Method of treatent
HK1208864A1 (en)	2016-03-18	A preparation method of ecteinascidin-743 intermediate -743
GB201215939D0 (en)	2012-10-24	Method of preparing monomers
EP2812301A4 (en)	2015-10-21	PROCESS FOR PREPARING ALCOHOLS
GB201202090D0 (en)	2012-03-21	Vaccine